| http://www.w3.org/ns/prov#value | - Critics, including Indian and international non-governmental organisations, argue that if the courts approve the company's demands it will be harder for Indian companies to produce the cheap generic versions of existing drugs that are used across the developing world to treat diseases such as malaria and HIV/AIDS.
|
